JD Health International revenue and financials
$35.14Change from previous close: +0.92%Absolute change: +$0.32
In the fiscal year ended December 2025, JD Health International reported revenue of ¥73.44B (+26.28% year over year). Net income was ¥5.38B, a net margin of 7.3%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +26.28%
- 2025 vs 2024
- Net income growth
- +29.16%
- 2025 vs 2024
- Net margin
- 7.3%
- 2024: 7.2%
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 73,441 | 58,160 | 53,530 | 46,736 |
| Cost of revenue | 55,242 | 44,851 | 41,665 | 36,845 |
| Gross profit | 18,199 | 13,309 | 11,865 | 9,892 |
| Selling, general and administrative | 5,005 | 4,468 | 4,653 | 4,349 |
| Research and development | 1,634 | 1,330 | 1,226 | 1,067 |
| Operating income | 3,941 | 1,479 | 701 | -46.9 |
| EBIT | 6,041 | 4,805 | 2,703 | 705 |
| EBITDA | 6,321 | 5,020 | 2,930 | 846 |
| Interest expense | 11.1 | 8.2 | 9.5 | 9.1 |
| Pre-tax income | 6,030 | 4,797 | 2,693 | 696 |
| Income tax | 663 | 640 | 550 | 313 |
| Net income | 5,375 | 4,162 | 2,142 | 380 |
| Net income to common shareholders | 5,375 | 4,162 | 2,142 | 380 |
| Basic EPS | 1.79 | 1.32 | 0.69 | 0.12 |
| Diluted EPS | 1.68 | 1.32 | 0.68 | 0.12 |
| Average shares (basic) | 3,163 | 3,143 | 3,124 | 3,107 |
| Average shares (diluted) | 3,196 | 3,160 | 3,164 | 3,144 |